![Piet A. M. Vervaet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Piet A. M. Vervaet
Geen lopende functies
Profiel
Dr. Piet A.
Vervaet, MD, is Vice President-Drug Safety & Pharmacovigilance at ARIAD Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Ghent and a doctorate degree from the University of Ghent.
Eerdere bekende functies van Piet A. M. Vervaet
Bedrijven | Functie | Einde |
---|---|---|
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Piet A. M. Vervaet
Ghent University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |